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Background: The extract of Entada gigas Linn. (Fabaceae) is used for the treatment of ulcer in Nigerian local 
medicine.  
Objectives: This study investigated the gastroprotective effects of the aqueous seed extract of E. gigas on gastric 
ulcers in rats.    
Methodology: The ethanol- (EIU), pylorus ligation- (PLIU) and cold restraint stress (CRSIU)-induced ulcer models 
were used. The aqueous seed extract was administered at doses of 50-400 mg/kg p.o. Estimations of gastric content 
volume, pH and titratable acidity in PLIU test and ulcer score/index in all models were done.  
Results: In the EIU test, E. gigas produced significant reduction (p < 0.05) in ulcer scores, with peak effect elicited at 
100 mg/kg (2.30 ± 0.99; 87.22% inhibition), compared with control (10.80 ± 0.80). This effect was comparable to 
that of misoprostol (3.00 ± 1.31; 83.33% inhibition). In the PLIU test, the extract caused significant reduction (p < 
0.05) in the ulcer score compared with control (6.30 ± 0.70). Peak effect was elicited at the dose of 200 mg/kg (ulcer 
score 2.90 ± 0.83; 63.17%). This effect was comparable to that of cimetidine (2.60 ± 0.93; 66.98%). Also, the extract 
at 50 and 200 mg/kg, and cimetidine 100 mg/kg (0.24 ± 0.07, 1.06 ± 0.22 and 1.02 ± 0.16 mL/4 h, respectively) 
significantly reduced (p < 0.05) the volume of gastric content relative to control (2.32 ± 0.33 mL/4 h). In the CRSIU 
test, E. gigas caused significant reduction (p < 0.05) in the ulcer score, with the greatest effect produced at the dose 
of 50 mg/kg (0.80 ± 0.49; 92.38% inhibition), relative to control (4.20 ± 0.64). This effect was comparable to that of 
misoprostol (1.40 ± 0.60; 80% inhibition).   
Conclusion: The aqueous seed extract of E. gigas possess significant antiulcer activity mediated via cytoprotective 
and anti-secretory mechanisms.   
Keywords: Entada gigas, Fabaceae, ulcer, gastroprotective effect, cytoprotective, anti-secretory.   
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1. Introduction 
Peptic ulcer is a common gastrointestinal disorder with 
high morbidity rate (Falk, 2001) and it results from 
established imbalance between the aggressive factors 
(e.g. gastric acid, pepsin and Helicobacter pylori) and 
defensive factors (e.g. bicarbonate secretion, 
prostaglandins, gastric mucus and innate resistance of 
the mucosal cells) (Dashputre and Naikwade, 2011; 
Srinivas et al, 2013). The causes of peptic ulcer include 
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infection with H. pylori, stress, injury/necrosis of mucus 
neck cells, excess acid production in the stomach and 
chronic use of aspirin and non-steroidal anti-
inflammatory drugs (NSAIDs) (Zdanowicz, 2002).    
Approximately 70% of the world population currently 
uses medicinal herbs as complementary or alternative 
medicine (Wills et al 2000; Fasinu et al, 2012). In recent 
years, focus on plant research has increased worldwide 
and several studies had showed immense potential of 
medicinal plants (Dahanukar et al, 2000). Herbal 
medicines are increasingly being recognized in treating 
various diseases, with relatively little knowledge of their 
modes of action (Begum et al, 2008), and the use of 
natural drugs in gastric ulcer has been reported (Sairam 
et al, 2001). Antiulcer chemical principles that have been 
isolated from plants include glycyrrhetinic acid from 
Glycyrrhiza glabra (Srinivas et al, 2013), populnoic acid 
from Austroplenckia populnea (Andrade et al, 2006), and 
the sesquiterpene lactone- tagitinin C from Tithonia 
diversifolia (Sánchez-Mendoza et al, 2011).     
Orthodox drugs available for the treatment of peptic 
ulcer disease such as anticholinergics, histamine H2-
receptor antagonists, antacids and proton-pump 
inhibitors cause many adverse effects (Adinortey et al, 
2013). Proton pump inhibitors (e.g. omeprazole and 
lansoprazole) may cause nausea, abdominal pain, 
constipation, diarrhea and H2-receptor antagonists 
(cimetidine) may cause gynecomastia and loss of libido 
(Srinivas et al, 2013). This has led to the search for herbal 
medicines possessing fewer side effects as alternatives 
for the treatment of peptic ulcer disease. This justifies the 
search for herbal remedies and new drugs with better or 
comparable efficacy and improved safety profile.     
Entada gigas (Linn.) Fawc. and Rendle (Fabaceae) is a 
liane with stout long stem climbing to the canopy of the 
evergreen and deciduous forests of West Africa. The 
plant is commonly called “Sea heart”, “Monkey ladder 
vine”, “Coco-de-Mer”, and “Escalera de mono”, with the 
local name being “Aagba” (Yoruba; south-west Nigeria). 
E. gigas is commonly found in West Africa from Guinea-
Bissau to Southern Nigeria and generally widespread in 
tropical Africa, Asia and N Australia. In Nigeria, a 
preparation of the aqueous seed extract of E. gigas is 
used in the treatment of gastrointestinal disorders, 
especially diarrhea and ulcer (Gunn and Dennis, 1976). 
The antimicrobial activity of E. gigas has been reported 
(Fankam et al, 2014). This study was designed to 
evaluate the gastroprotective effects of the aqueous seed 
extract of E. gigas, based on use in traditional medicine 
in Nigeria, on gastric ulcers induced in rats. 
2. Methodology 
2.1 Drugs and Chemicals  
Cimetidine (Yanzhou Xier Kangtai Pharmaceutical Co. 
Ltd., China), misoprostol (Cytotec®, Pfizer 
Pharmaceuticals, NY, USA), indomethacin (Yangzhou No. 
3 Pharmaceutical Co. Ltd., China), absolute ethanol 
(Sigma-Aldrich, MO, USA), formalin (Griffin & George, 
Leicestershire, England), potassium chloride, urethane 
(Sigma-Aldrich, Germany), chloralose (BDH Chemical 
Ltd., Poole, England), phenolphthalein, sodium 
hydroxide, and distilled water.   
2.2 Experimental Animals    
Healthy female albino mice (20 g average weight) and 
female Sprague-Dawley rats (180 g average weight) used 
in this study were obtained from the Laboratory Animal 
Center of the College of Medicine of the University of 
Lagos, Lagos, Nigeria. Experimental animals were kept in 
a well-ventilated room and were maintained under 
standard environmental conditions (23-25oC, 12 h/12 h 
light/dark cycle). The animals had free access to 
standard rodent diet (Livestock Feeds Plc., Lagos, 
Nigeria) and water. All the animals were acclimatized for 
one week prior to the commencement of experimental 
procedures. The experiments were performed between 
9.00 am and 6.00 pm on assigned days. The procedures 
were carried out in compliance with the United States 
National Academy of Sciences Guide for the Care and Use 
of Laboratory Animals (Committee for the Update of the 
Guide for the Care and Use of Laboratory Animals, 2011) 
and the provisions of the Experimentation Ethics 
Committee on Animal Use of the College of Medicine, 
University of Lagos, Lagos, Nigeria.    
2.3 Plant Material  
The fresh seeds of E. gigas were obtained from local herb 
sellers at Mushin market in Mushin Local Government 
Area, Lagos State, Nigeria. The plant material was 
validated based on an existing identification and 
authentication done by Mr. O.O. Oyebanji of the 
Department of Botany and Microbiology, Faculty of 
Science, University of Lagos, Lagos, Nigeria. The voucher 
specimen (LUH 5595) was deposited in the institutional 
herbarium for reference purpose.    
2.4 Extraction   
The dark brown seeds of E. gigas were broken and the 
inner whitish flesh was removed and pulverized using a 
blender. Three hundred and fifty grams (350 g) of the 
powdered plant material was macerated in 2.5 L of 
distilled water for 48 h in the refrigerator with 
intermittent agitation to enhance extraction. Thereafter, 
the extract was decanted and filtered using Whatman 
(1.0) filter paper. The residue was re-macerated in 2.5 L 
of distilled water (× 2) to ensure exhaustive extraction. 
The filtrate was evaporated to dryness in a lab drying 
oven at 40 °C. A sticky, dark brown solid extract with 
sweet coffee-like smell and bitter taste was obtained 
with a yield of 66.74%. The solid extract showed 
hygroscopic properties in readily absorbing moisture on 
exposure to air. It produced foams when dissolved in 
water and shaken. The extract was put in sample bottles 
and stored in the refrigerator at 4 °C. When required, a 
specific amount of the extract was weighed out and 
dissolved in distilled water to give the desired 
concentration for administration to experimental 
animals. The doses of the extract used in this study (50, 
100, 200 and 400 mg/kg) were based on results of 
preliminary investigations and oral acute toxicity test.    
2.5 Determination of Total Flavonoids, 
Proanthocyanidins and Phenolic Content     Twenty-
five (25) g of E. gigas aqueous extract was dissolved in 25 
ml of methanol to give a solution concentration of 1 
mg/mL. In order to aid the dissolvability of the extract, 
sonication of the solution was carried out using Olympus 
KS-2 Ultrasonic bath. The solution was then filtered 
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using Whatman filter paper 1.0. The filtrate was used for 
the phytochemical analysis. The determination of total 
flavonoids, proanthocyanidins and phenolic content was 
done as reported by Sofidiya et al, (2009).         
2.6 Acute Toxicity Test 
The acute toxicity of the extract was determined using 
the OECD guidelines for the testing of chemicals; acute 
oral toxicity- limit test at 5000 mg/kg (OECD, 2001). Five 
(5) albino mice used for the procedure were fasted for 12 
h prior to the test. The extract was administered orally at 
the dose of 5000 mg/kg. The control group received 
distilled water at the volume corresponding to the 
highest volume of extract administered to the test animal 
group. The animals were observed closely for 
behavioural changes and toxic/lethal symptoms for 2 h 
post-treatment (Akindele et al, 2015). Mortality within 
24 h was recorded and the animals were continually 
observed for 14 days after administration for signs of 
delayed toxicity.       
2.7 Antiulcer Activity Evaluation     
2.7.1 Ethanol-Induced Ulcer (EIU) Test  
Animals were fasted for 24 h prior to the experiment and 
randomly allotted into six groups of five rats each. The 
animals were pre-treated twice daily for 5 days as 
follows: 
Group 1: Distilled water (10 ml/kg, p.o.).  
Group 2: E. gigas aq. seed extract (50 mg/kg p.o.) 
Group 3: E. gigas aq. seed extract (100 mg/kg p.o.) 
Group 4: E. gigas aq. seed extract (200 mg/kg p.o.) 
Group 5: E. gigas aq. seed extract (400 mg/kg p.o.) 
Group 6: Misoprostol (a prostaglandin analogue with 
gastric cytoprotective activity; 50 μg/kg p.o.)  
The rats were fasted for 24 h into the 6th day. Gastric 
ulcer was induced in the rats by administration of 
absolute ethanol (1 ml/200 g p.o.) (Hollander et al, 
1985). After 1 h, the animals were sacrificed by cervical 
dislocation, after being anaesthetized with 1 ml/200 g 
(i.p.) solution of 25% urethane and 1% chloralose, and 
the stomach was isolated and incised along the greater 
curvature. The gastric lumen was rinsed with normal 
saline and examined for ulcers. Ulcer score was 
determined using the Magistreni scale (Magistretti et al, 
1988). The tissues were then fixed in 10% formol-saline 
for histopathological assessment.      
2.7.2 Pylorus Ligation-Induced Ulcer (PLIU) Test  
The same treatment schedule for the ethanol-induced 
ulcer test was adopted except that cimetidine (a 
histamine H2-receptor antagonist that inhibits stomach 
acid secretion) 100 mg/kg was used as positive control. 
The rats were fasted for 24 h into the 6th day and were 
anaesthetized using 25% urethane and 1% chloralose 
(i.p.) at a dose of 1 ml of mixture/200 g weight. 
Tracheotomy was done to remove bronchial secretion 
and the abdomen was opened, and pylorus ligation done 
without causing any damage to the blood supply. The 
stomach was replaced carefully and the abdominal wall 
was closed in two layers with a moist swab of normal 
saline. After 4 h, each stomach was dissected out and cut 
open along the greater curvature. Ulcer was scored using 
the Magistreni scale. The volume of gastric juice collected 
from each rat was determined using a measuring 
cylinder and the pH was thereafter measured. The 
centrifuged gastric juice from each pylorus-ligated rat 
was titrated against 0.01 N NaOH using phenolphthalein 
indicator and the pH was determined using a research 
ionalyzer (Orion, Beverly, MA, USA). All measurements 
were done in triplicate. Titratable acidity was 
determined and expressed as mEq/ml (Segawa et al, 
1994; Kakub and Gulfraz, 2007).      
2.7.3 Cold Restraint Stress-Induced Ulcer (CRSIU) 
Test      
The same treatment schedule for the ethanol-induced 
ulcer test was adopted. Upon 24 h fasting from the 5th to 
the 6th day, rats were immobilized by strapping the fore 
and hind limbs on a flat receptive platform, and kept at a 
temperature of 4-6 °C for 2 h (Gupta et al, 1985). 
Thereafter, each rat was sacrificed as previously 
described above and the stomach was incised along the 
greater curvature. The lumen was rinsed with normal 
saline, examined and scored for ulcer using the 
Magistreni scale.  
2.7.4 Ulcer Scoring Scale and Calculation of Ulcer 
Index and Inhibition (%)  
Ulcer Scoring Scale   
0 = no lesion 
0.5 = hemorrhage 
1 = 1-3 small lesions (10 mm length) 
2 = 1-3 large lesions (10 mm length) 
3 = 1-3 thickened lesions 
4 = more than 3 small lesions  
5 = more than 3 large lesions 
6 = more than 3 thickened lesions (Magistretti et al, 
1988)      
Calculation of Ulcer Index and Inhibition (%)  
 UI = ADU × (%RU/100) 
Where ADU is the average degree of ulceration for each 
group (mean ulcer score) and %RU is the percentage of 
rats with ulceration (Thuillier et al, 1968).     
 Inhibition (%) = ([UIC – UIT]/UIC) × 100   
Where UIC is the ulcer index for the control group and UIT 
is the ulcer index for the treatment group.  
2.8 Statistical Analysis 
The results obtained in this study were expressed as 
mean ± S.E.M. (standard error of mean). Data were 
analyzed using one-way ANOVA using Dunnett’s post-
hoc test (GraphPad Prism 6, GraphPad Software Inc., CA, 
USA) and Student’s t-test (unpaired; two-tailed) for 
independent comparisons where applicable). Values 
were considered significant at p < 0.05. 
 Akindele et al, Afr. J. Pharmacol. Ther. 2016. 5(3): 155-162 
 
 
A KeSoBAP Publication ©2016. All rights reserved.  ISSN 2303-9841 
158 
3.  Results  
3.1 Determination of Total Flavonoids, 
Proanthocyanidins and Phenolic Content     
Flavonoids, proanthocyanidins, and phenolic 
compounds were present in the aqueous seed extract of 
E. gigas. The total flavonoids, proanthocyanidins and 
phenolic content were estimated to be 9.898 mg/g, 8.346 
mg/g, and 105.476 mg/g of the extract, respectively.   
3.2 Acute Toxicity Test  
The aqueous seed extract of E. gigas administered orally 
to mice at the dose of 5000 mg/kg neither caused 
mortality nor produced toxic/lethal signs.   
3.3 Ethanol-Induced Ulcer Test  
Ulcer Score and Index  
E. gigas (50-400 mg/kg) and misoprostol (50 µg/kg) 
produced significant reduction (p < 0.05-0.001) in ulcer 
scores compared with control (10.80 ± 0.80).  
The greatest reduction was produced at the extract dose 
of 100 mg/kg (ulcer score 2.30 ± 0.99; 87.22% 
inhibition). This effect was comparable and not 
significantly different (p > 0.05) from that elicited by 
misoprostol (ulcer score 3.00 ± 1.31; 83.33% inhibition) 
(Table 1).    
    Table 1: Effect of E. gigas on ethanol-induced ulcer in rats   
Treatment and dose Ulcer score Ulcer index Inhibition (%) 
Distilled water 10 ml/kg 10.80 ± 0.80 10.80 - 
E. gigas 50 mg/kg 5.40 ± 0.87* 5.40 50.00 
E. gigas 100 mg/kg 2.30 ± 0.99*** 1.38 87.22 
E. gigas 200 mg/kg 4.70 ± 1.51* 4.70 56.48 
E. gigas 400 mg/kg 3.30 ± 1.38** 2.64 75.56 
Misoprostol 50 μg/kg 3.00 ± 1.31*** 1.80 83.33 
Values are expressed as Mean ± S.E.M. (n = 5). *p < 0.05, **p < 0.01, ***p < 0.001 vs. distilled water (one-
way ANOVA with Dunnett’s post-hoc test).       
 
    Table 2: Effect of E. gigas on pylorus ligation-induced ulcer in rats  
Treatment and dose Ulcer score Ulcer index Inhibition (%) 
Distilled water 10 ml/kg  6.30 ± 0.70 6.30 - 
E. gigas 50 mg/kg 4.60 ± 1.18 3.68 41.59 
E. gigas 100 mg/kg 3.40 ± 0.94# 2.72 56.83 
E. gigas 200 mg/kg 2.90 ± 0.83# 2.32 63.17 
E. gigas 400 mg/kg 3.50 ± 0.92# 3.50 44.44 
Cimetidine 100 mg/kg 2.60 ± 0.93*,# 2.08 66.98 
Values are expressed as Mean ± S.E.M. (n = 5). *,#p < 0.05 vs. distilled water (*one-way ANOVA with 
Dunnett’s post-hoc test; #Student’s t-test, unpaired and two-tailed). 
 
Table 3: Effect of E. gigas on gastric content volume, pH and titratable acidity in pylorus ligation-induced ulcer in rats   
Treatment and dose Volume of gastric 






Distilled water 10 ml/kg 2.32 ± 0.33 - 2.98 ± 0.18 2.17 ± 0.36 
E. gigas 50 mg/kg 0.24 ± 0.07*** 89.66 3.26 ± 0.13 1.75 ± 0.42 
E. gigas 100 mg/kg 1.40 ± 0.43 39.66 3.28 ± 0.02 1.18 ± 0.18 
E. gigas 200 mg/kg 1.06 ± 0.22* 54.31 3.08 ± 0.15 1.32 ± 0.31 
E. gigas 400 mg/kg 1.26 ± 0.34 45.69 2.98 ± 0.13 1.76 ± 0.34 
Cimetidine 100 mg/kg  1.02 ± 0.16* 56.03 3.70 ± 0.20* 0.97 ± 0.18 
Values are expressed as Mean ± S.E.M. (n = 5). *p < 0.05, ***p < 0.001 vs. distilled water (one-way ANOVA with Dunnett’s post-hoc test). 
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Figure 1: Photomicrographs of rat gastric representative tissue for the ethanol-induced ulcer test treated with distilled 
water 10 ml/kg (A; showing full thickness mucosal necrosis/ulceration and sub-mucosal inflammation); E. gigas 100 
mg/kg (B; showing superficial mucosal necrosis/erosion); and misoprostol 50 μg/kg (C; showing normal histologic 
section with gastric mucosa without areas of necrosis or inflammation) (× 100). 
 
     Table 4: Effect of E. gigas on cold restraint stress-induced ulcer in rats     
Treatment and dose Ulcer score Ulcer index Inhibition (%) 
Distilled water 10 ml/kg 4.20 ± 0.64 4.20 - 
E. gigas 50 mg/kg 0.80 ± 0.49** 0.32 92.38 
E. gigas 100 mg/kg 3.00 ± 0.76 2.40 42.86 
E. gigas 200 mg/kg 1.30 ± 0.80* 0.52 87.62 
E. gigas 400 mg/kg 1.00 ± 0.63** 0.40 90.48 
Misoprostol 50 μg/kg 1.40 ± 0.60* 0.84 80.00 
Values are expressed as Mean ± S.E.M. (n = 5). *p < 0.05 vs. distilled water (one-way ANOVA with Dunnett’s 
post-hoc test). 
Histopathological Assessment of Gastric Tissue  
As shown in Figure 1, photomicrographs of rat gastric 
representative tissue for the ethanol-induced ulcer test 
revealed full thickness mucosal necrosis/ulceration and 
sub-mucosal inflammation for distilled water 10 mL/kg, 
superficial mucosal necrosis/erosion for E. gigas 100 
mg/kg, and normal histologic section with gastric 
mucosa without areas of necrosis or inflammation for 
misoprostol 50 μg/kg. 
3.4 Pylorus Ligation-Induced Ulcer Test   
Ulcer Score and Index    
The extract (100-400 mg/kg) caused significant 
reduction (p < 0.05) in the ulcer score compared with 
control (6.30 ± 0.70). The inhibition of ulcer 
development was highest at the dose of 200 mg/kg (ulcer 
score 2.90 ± 0.83; 63.17%). Cimetidine produced 
significant reduction (p < 0.05) in the ulcer score (2.60 ± 
0.93; 66.98%) relative to control. The effect of cimetidine 
was not significantly different (p > 0.05) from the effects 
of E. gigas at all doses tested (Table 2).      
Gastric Content Volume, pH and Titratable Acidity   
E. gigas at 50 and 200 mg/kg, and cimetidine 100 mg/kg 
(0.24 ± 0.07, 1.06 ± 0.22 and 1.02 ± 0.16 ml/4 h, 
respectively) significantly reduced (p < 0.01, 0.001) the 
volume of gastric content relative to control (2.32 ± 0.33 
ml/4 h) with reduction in volume (%) values of 89.66, 
54.31 and 56.03%, respectively.  
The effect of the extract in reducing the gastric content 
volume at 50 mg/kg was greater than that elicited by 
cimetidine, while the value for E. gigas at 200 mg/kg was 
comparable to that of the standard drug. The extract at 
all doses used did not significantly alter (p > 0.05) the pH 
and titratable acidity of the gastric content compared 
with control. Cimetidine significantly increased (p < 
0.05) the pH but not titratable acidity value relative to 
control (Table 3).   
3.5 Cold Restraint Stress-Induced Ulcer Test  
3.5.1 Ulcer Score and Index    
E. gigas at doses of 50, 200 and 400 mg/kg caused 
significant reduction (p < 0.05, 0.01) in the ulcer score, 
with the greatest effect produced at the dose of 50 mg/kg 
(0.80 ± 0.49; 92.38% inhibition), relative to control (4.20 
± 0.64). However, the effect of the extract at the dose of 
50 mg/kg was comparable and not significantly different 
(p > 0.05) from the result at other extract doses and that 
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4. Discussion 
Peptic ulcers, with gastric and duodenal ulcers being the 
most common, result from an imbalance between 
aggressive (hydrochloric acid, pepsin, refluxed bile, 
leukotrienes, and reactive oxygen species) and defensive 
(mucus-bicarbonate barrier, prostaglandins, mucosal 
blood flow, cell renewal and migration, non-enzymatic 
and enzymatic antioxidants, and some growth factors) 
factors (Amandeep et al, 2012). In this study, the 
aqueous seed extract of E. gigas was evaluated for 
gastroprotective effects using the ethanol-, pylorus 
ligation-, and cold restraint stress-induced ulcer tests in 
rats.  
Ethanol is a corrosive agent that penetrates the gastric 
mucosa due to its ability to solubilize the protective 
mucous and expose the mucosa to the proteolytic and 
hydrolytic activity of hydrochloric acid secreted from the 
parietal cells of the stomach and pepsin (Soll, 1990; 
Surendra, 1999). It has been reported that the incidence 
of ethanol-induced ulcer is predominant in the glandular 
part of the stomach and ethanol stimulate the formation 
of leukotriene C4 (LTC4), mast cell secretory products, 
and reactive oxygen (Salim, 1990). In this model, E. gigas 
(50-400 mg/kg) produced significant reduction in ulcer 
development with the most prominent effect produced 
at the dose of 100 mg/kg (87.22% inhibition). This effect 
was comparable to that elicited by misoprostol (83.33% 
inhibition). The biphasic inhibitory action of E. gigas 
(observation of greatest effects at 100 and 400 mg/kg 
with peak effect at the lower dose) may be explained by 
the concept of Hormesis. Hormesis is a biphasic dose 
response to an agent characterized by low dose 
stimulation or beneficial effect and a high dose inhibitory 
or toxic effect (Mattson, 2008). Photomicrographs of rat 
gastric representative tissue for this test revealed 
superficial mucosal erosion for the extract at the dose of 
100 mg/kg compared with full thickness mucosal 
ulceration for the negative control. The findings in the 
ethanol-induced ulcer test suggest that the extract 
possibly reduced the ability of the ulcerogen to solubilize 
the protective gastric mucous layer- a direct 
cytoprotective effect. This effect may be due to increased 
mucus secretion (a possibility that needs to be further 
investigated) or enhanced mucosal resistance that 
prevents damage of the gastric mucosa.   
The digestive effect of accumulated gastric juice and 
interference of gastric blood circulation are responsible 
for the induction of ulceration by pylorus ligation 
(Khushtar et al, 2009; Patel et al, 2000). According to 
Sairam et al, (2002), pylorus ligation-induced ulcers are 
due to the auto-digestion of the gastric mucosa and 
breakdown of the gastric mucosal barrier. In this model, 
the extract (100-400 mg/kg) caused significant 
reduction in ulcer development with peak inhibitory 
effect at the dose of 200 mg/kg (63.17%). The biphasic 
inhibitory effect of the extract in this test may also be 
attributed to Hormesis. The maximal effect of the extract 
was comparable to that of 100 mg/kg cimetidine (a 
histamine H2-receptor antagonist that inhibits stomach 
acid secretion; 66.98% inhibition). E. gigas at 50 and 200 
mg/kg, and cimetidine significantly reduced the volume 
of gastric content with reduction in volume (%) values of 
89.66, 54.31 and 56.03%, respectively. However, E. gigas 
did not significantly change the pH and titratable acidity 
of the gastric content. The findings in this test suggests 
that E. gigas possesses anti-secretory property. It is 
however not clear if this effect is general or specific to 
certain gastric secretory cells.  
Ulceration in the cold restraint stress model is mainly 
due to increased acid secretion and generation of free 
radicals which cause oxidative gastric mucosal damage 
(Vijayakumar et al, 2011). E. gigas (50, 200 and 400 
mg/kg) caused significant reduction in ulcer 
development with the most pronounced effect elicited at 
the dose of 50 mg/kg (92.38% inhibition). As with the 
other two models, the greatest ulcer development 
inhibitory effect was observed at the lower dose, a 
phenomenon which had earlier been ascribed to the 
concept of Hormesis. The peak effect of the extract in this 
model was comparable to that produced by misoprostol 
(80% inhibition). The action of E. gigas in the cold 
restraint stress test may be due to its anti-secretory 
property, as established in the pylorus ligation model.  
In respect of acute toxicity, oral administration of E. gigas 
(5000 mg/kg) did not produce any mortality or 
symptoms of toxicity in the treated mice. 14 days post-
acute oral administration, no mortality and significant 
change in behavior of the animals was observed. Loomis 
and Hayes (1996) described the classification of some 
chemical agents into categories of toxicity in which the 
dose of 5000 mg/kg was categorized as practically non-
toxic. This suggests that the extract is relatively safe 
administered orally.     
Phytochemical analysis of E. gigas revealed the presence 
of flavonoids, proanthocyanidins and phenolic 
compounds. These phytoconstituents are known 
antioxidants with free radicals scavenging properties. 
Although the extract did not cause significant change in 
gastric tissue antioxidant indices in the cold restraint 
stress model (results not shown), this possibility needs 
to be specifically and broadly explored. Flavonoids are 
known to reduce gastric ulcer formation (Suzuki et al, 
1998), hence may contribute in part to the antiulcer 
activity of the extract observed in this study. Wittschier 
et al, (2007) reported that proanthocyanidins present 
potential prophylactic tools against specific bacterial 
infections including H. pylori, Campylobacter jejuni etc. 
As earlier mentioned, the antimicrobial activity of E. 
gigas had previously been reported (Fankam et al, 2014). 
In view of this fact, the proanthocyanidins content of E. 
gigas may also contribute important prophylactic effects 
by antagonizing the adhesive interaction of these 
bacteria to the gastrointestinal tract. However, this 
possibility needs to be further investigated. 
5. Conclusion 
The results obtained in this study suggest that the 
aqueous seed extract of Entada gigas possess 
gastroprotective effects possibly mediated via 
cytoprotective and anti-secretory activities and 
associated with the presence of flavonoids, 
proanthocyanidins and phenolic compounds detected. 
However, further studies are ongoing to isolate, 
elucidate and characterize the precise chemical 
principle(s) responsible for the established 
gastroprotective effects of the extract and determine the 
mechanism(s) of action, including possible 
antioxidant/radical scavenging activities. The findings in 
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this study justify the use of the extract for the treatment 
of ulcer traditionally. 
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